These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1307 related articles for article (PubMed ID: 29051185)

  • 1. cGMP-Elevating Compounds and Ischemic Conditioning Provide Cardioprotection Against Ischemia and Reperfusion Injury via Cardiomyocyte-Specific BK Channels.
    Frankenreiter S; Bednarczyk P; Kniess A; Bork NI; Straubinger J; Koprowski P; Wrzosek A; Mohr E; Logan A; Murphy MP; Gawaz M; Krieg T; Szewczyk A; Nikolaev VO; Ruth P; Lukowski R
    Circulation; 2017 Dec; 136(24):2337-2355. PubMed ID: 29051185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardioprotection by ischemic postconditioning and cyclic guanosine monophosphate-elevating agents involves cardiomyocyte nitric oxide-sensitive guanylyl cyclase.
    Frankenreiter S; Groneberg D; Kuret A; Krieg T; Ruth P; Friebe A; Lukowski R
    Cardiovasc Res; 2018 May; 114(6):822-829. PubMed ID: 29438488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KCNMA1 encoded cardiac BK channels afford protection against ischemia-reperfusion injury.
    Soltysinska E; Bentzen BH; Barthmes M; Hattel H; Thrush AB; Harper ME; Qvortrup K; Larsen FJ; Schiffer TA; Losa-Reyna J; Straubinger J; Kniess A; Thomsen MB; Brüggemann A; Fenske S; Biel M; Ruth P; Wahl-Schott C; Boushel RC; Olesen SP; Lukowski R
    PLoS One; 2014; 9(7):e103402. PubMed ID: 25072914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological options to protect the aged heart from ischemia and reperfusion injury by targeting the PKA-BK(Ca) signaling pathway.
    Heinen A; Ströthoff M; Schmidt A; Stracke N; Behmenburg F; Bauer I; Hollmann MW; Huhn R
    Exp Gerontol; 2014 Aug; 56():99-105. PubMed ID: 24727217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological activation of soluble guanylate cyclase protects the heart against ischemic injury.
    Korkmaz S; Radovits T; Barnucz E; Hirschberg K; Neugebauer P; Loganathan S; Veres G; Páli S; Seidel B; Zöllner S; Karck M; Szabó G
    Circulation; 2009 Aug; 120(8):677-86. PubMed ID: 19667237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection through postconditioning or a mitochondria-targeted S-nitrosothiol is unaffected by cardiomyocyte-selective ablation of protein kinase G.
    Methner C; Lukowski R; Grube K; Loga F; Smith RA; Murphy MP; Hofmann F; Krieg T
    Basic Res Cardiol; 2013 Mar; 108(2):337. PubMed ID: 23423145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of ischaemic preconditioning in the eNOS overexpressed working mouse heart model.
    du Toit EF; Genade S; Carlini S; Moolman JA; Brunner F; Lochner A
    Eur J Pharmacol; 2007 Feb; 556(1-3):115-20. PubMed ID: 17157294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postconditioning--A new link in nature's armor against myocardial ischemia-reperfusion injury.
    Vinten-Johansen J; Zhao ZQ; Zatta AJ; Kin H; Halkos ME; Kerendi F
    Basic Res Cardiol; 2005 Jul; 100(4):295-310. PubMed ID: 15793629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. cGMP and mitochondrial K
    Lukowski R; Cruz Santos M; Kuret A; Ruth P
    Br J Pharmacol; 2022 Jun; 179(11):2344-2360. PubMed ID: 33991427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclic GMP and protein kinase-G in myocardial ischaemia-reperfusion: opportunities and obstacles for survival signaling.
    Burley DS; Ferdinandy P; Baxter GF
    Br J Pharmacol; 2007 Nov; 152(6):855-69. PubMed ID: 17700722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the nitric oxide/cyclic guanosine monophosphate pathway limited the cardioprotective effect of post-conditioning in hearts with apical myocardial infarction.
    Correa F; Buelna-Chontal M; Chagoya V; García-Rivas G; Vigueras RM; Pedraza-Chaverri J; García-Niño WR; Hernández-Pando R; León-Contreras JC; Zazueta C
    Eur J Pharmacol; 2015 Oct; 765():472-81. PubMed ID: 26387613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neurovascular mechanism of clitoral erection: nitric oxide and cGMP-stimulated activation of BKCa channels.
    Gragasin FS; Michelakis ED; Hogan A; Moudgil R; Hashimoto K; Wu X; Bonnet S; Haromy A; Archer SL
    FASEB J; 2004 Sep; 18(12):1382-91. PubMed ID: 15333581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remifentanil Preconditioning Reduces Postischemic Myocardial Infarction and Improves Left Ventricular Performance via Activation of the Janus Activated Kinase-2/Signal Transducers and Activators of Transcription-3 Signal Pathway and Subsequent Inhibition of Glycogen Synthase Kinase-3β in Rats.
    Qiao S; Mao X; Wang Y; Lei S; Liu Y; Wang T; Wong GT; Cheung CW; Xia Z; Irwin MG
    Crit Care Med; 2016 Mar; 44(3):e131-45. PubMed ID: 26468894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble guanylyl cyclase activation improves progressive cardiac remodeling and failure after myocardial infarction. Cardioprotection over ACE inhibition.
    Fraccarollo D; Galuppo P; Motschenbacher S; Ruetten H; Schäfer A; Bauersachs J
    Basic Res Cardiol; 2014 Jul; 109(4):421. PubMed ID: 24907870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardioprotection by H2S engages a cGMP-dependent protein kinase G/phospholamban pathway.
    Bibli SI; Andreadou I; Chatzianastasiou A; Tzimas C; Sanoudou D; Kranias E; Brouckaert P; Coletta C; Szabo C; Kremastinos DT; Iliodromitis EK; Papapetropoulos A
    Cardiovasc Res; 2015 Jun; 106(3):432-42. PubMed ID: 25870184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of inducible nitric oxide synthase in the diabetic heart compromises ischemic postconditioning.
    Wang TT; Shi MM; Liao XL; Li YQ; Yuan HX; Li Y; Liu X; Ning DS; Peng YM; Yang F; Mo ZW; Jiang YM; Xu YQ; Li H; Wang M; Ou ZJ; Xia Z; Ou JS
    J Mol Cell Cardiol; 2019 Apr; 129():144-153. PubMed ID: 30797815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective role of cardiac CFTR activation upon early reperfusion against myocardial infarction.
    Uramoto H; Okada T; Okada Y
    Cell Physiol Biochem; 2012; 30(4):1023-38. PubMed ID: 23221371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bradykinin induces mitochondrial ROS generation via NO, cGMP, PKG, and mitoKATP channel opening and leads to cardioprotection.
    Oldenburg O; Qin Q; Krieg T; Yang XM; Philipp S; Critz SD; Cohen MV; Downey JM
    Am J Physiol Heart Circ Physiol; 2004 Jan; 286(1):H468-76. PubMed ID: 12958031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial LonP1 protects cardiomyocytes from ischemia/reperfusion injury in vivo.
    Venkatesh S; Li M; Saito T; Tong M; Rashed E; Mareedu S; Zhai P; Bárcena C; López-Otín C; Yehia G; Sadoshima J; Suzuki CK
    J Mol Cell Cardiol; 2019 Mar; 128():38-50. PubMed ID: 30625302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermittent activation of bradykinin B2 receptors and mitochondrial KATP channels trigger cardiac postconditioning through redox signaling.
    Penna C; Mancardi D; Rastaldo R; Losano G; Pagliaro P
    Cardiovasc Res; 2007 Jul; 75(1):168-77. PubMed ID: 17400201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 66.